| ²é¿´: 497 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß spxysa041 µÄ 2 ¸ö½ð±Ò | |||
spxysa041½ð³æ (ÕýʽдÊÖ)
|
[½»Á÷]
¡¾ÇóÖú¡¿Ò»¸öҽѧÏà¹Øµ¥´ÊµÄÒâ˼ ÒÑÓÐ2È˲ÎÓë
|
||
|
chylomicrons from individual animals were pooled, according to which dietary fat they consumed, and respun under the same conditions, 8.75 mg of chylomicron triacylglycerol was then incubated at 37¡ãC with 2.5 ml of post-heparin plasma in 12 ml of 0.15 M NaC1 containing 5% (w/w) fatty acid free BSA (Sigma, Dorset, UK). In vitro hydrolysis of chylomicron TAG was performed essentially as described by Floren and Nilsson ÇëÎÊÕâ¾äÖÐµÄ respun ÊÇʲôÒâ˼£¬Õâ¸ö´ÊµÄÔÐÍÊÇʲô£¿Ð»Ð» [ Last edited by spxysa041 on 2010-4-19 at 08:34 ] |
» ²ÂÄãϲ»¶
ÆÚ¿¯Letters in drug design & discoveryͶ¸åÇóÖú
ÒѾÓÐ10È˻ظ´
ÆÚ¿¯Letters in drug design & discoveryͶ¸åÇóÖú
ÒѾÓÐ0È˻ظ´
ÃÚÄòϵͳÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ291È˻ظ´
»¤Àíר˶304·Ö£¬´óѧËÄÄê³É¼¨¾ùΪרҵµÚÒ»£¡Çóµ÷¼Á£¡
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸ºÓÄÏ´óѧ»¤Àíר˶£¡À´¸öÀÏʦÊÕÁôÎÒ£¬¾ø²»»áºó»Ú£¡
ÒѾÓÐ5È˻ظ´
ҽѧ¿¼Ñе÷¼Á
ÒѾÓÐ1È˻ظ´
ÎÄÏ×ÇóÖú£¬¼±¼±¼±£¡£¡£¡£¡
ÒѾÓÐ2È˻ظ´
qshjdax
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1469.7
- Ìû×Ó: 247
- ÔÚÏß: 4.7Сʱ
- ³æºÅ: 861825
- ×¢²á: 2009-10-02
- רҵ: ÐÅÏ¢°²È«
2Â¥2010-04-18 21:29:10
301_songzhou
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 6.9
- Ìû×Ó: 11
- ÔÚÏß: 38·ÖÖÓ
- ³æºÅ: 994016
- ×¢²á: 2010-04-11
3Â¥2010-04-19 00:22:16














»Ø¸´´ËÂ¥